Literature DB >> 2719009

Coffee and alcohol use and the risk of ulcerative colitis.

E J Boyko1, D R Perera, T D Koepsell, E M Keane, T S Inui.   

Abstract

We performed a population-based, case-control study of the risk of ulcerative colitis associated with coffee and alcohol use among the 304,000 members of a prepaid health plan. We compared coffee and alcohol use histories before ulcerative colitis onset in 209 cases and an equal number of age- and sex-matched controls selected from the enrollment file of the prepaid health plan. Neither coffee use, amount of coffee consumed daily, or cumulative coffee consumption before disease onset altered the risk of developing ulcerative colitis. A decreased risk of ulcerative colitis was associated with alcohol consumption before disease onset among never-smokers only. This risk declined as daily alcohol consumption increased. These results suggest that alcohol consumption may lower ulcerative colitis incidence.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2719009

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  12 in total

Review 1.  The role of cigarettes and nicotine in the onset and treatment of ulcerative colitis.

Authors:  J Birtwistle
Journal:  Postgrad Med J       Date:  1996-12       Impact factor: 2.401

2.  Ulcerative colitis associated with the herbal weight loss supplement Hydroxycut.

Authors:  Vernon Sivarajah; Quddus Abdul; Helen Pardoe; Peter Lunniss
Journal:  BMJ Case Rep       Date:  2013-01-03

3.  Multicenter case-control study of the risk factors for ulcerative colitis in China.

Authors:  Yu-Fang Wang; Qin Ou-Yang; Bing Xia; Li-Na Liu; Fang Gu; Kai-Fang Zhou; Qiao Mei; Rui-Hua Shi; Zhi-Hua Ran; Xiao-Di Wang; Pin-Jin Hu; Kai-Chun Wu; Xin-Guang Liu; Ying-Lei Miao; Ying Han; Xiao-Ping Wu; Guo-Bing He; Jie Zhong; Guan-Jian Liu
Journal:  World J Gastroenterol       Date:  2013-03-21       Impact factor: 5.742

Review 4.  Role of the endothelium in inflammatory bowel diseases.

Authors:  Walter E Cromer; J Michael Mathis; Daniel N Granger; Ganta V Chaitanya; J Steven Alexander
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

5.  MEFV gene mutations and its impact on the clinical course in ulcerative colitis patients.

Authors:  Beytullah Yıldırım; Candan Tuncer; Derya Kan; Bilge Tunc; Mehmet Derya Demirag; E Ferda Percın; Seminur Haznedaroglu; Hakan Alagozlu
Journal:  Rheumatol Int       Date:  2010-03-12       Impact factor: 2.631

6.  No association of alcohol use and the risk of ulcerative colitis or Crohn's disease: data from a European Prospective cohort study (EPIC).

Authors:  M M Bergmann; V Hernandez; W Bernigau; H Boeing; S S M Chan; R Luben; K-T Khaw; F van Schaik; B Oldenburg; B Bueno-de-Mesquita; K Overvad; D Palli; G Masala; F Carbonnel; M-C Boutron-Ruault; A Olsen; A Tjonneland; R Kaaks; V Katzke; E Riboli; A R Hart
Journal:  Eur J Clin Nutr       Date:  2017-01-25       Impact factor: 4.016

Review 7.  Epidemiology and inflammatory bowel diseases.

Authors:  Ahmed Mahmoud El-Tawil
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

8.  Effect of Alcoholic Intoxication on the Risk of Inflammatory Bowel Disease: A Nationwide Retrospective Cohort Study.

Authors:  Tai-Yi Hsu; Hong-Mo Shih; Yu-Chiao Wang; Leng-Chieh Lin; Guan-Yi He; Chih-Yu Chen; Chia-Hung Kao; Chao-Hsien Chen; Wei-Kung Chen; Tse-Yen Yang
Journal:  PLoS One       Date:  2016-11-01       Impact factor: 3.240

9.  Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis.

Authors:  Jin Lee; Sam Ryong Jee; Hyung Wook Kim; Dong Hoon Baek; Geun Am Song; Won Moon; Seun Ja Park; Hyun Jin Kim; Jong Hoon Lee; Jong Ha Park; Tae Oh Kim
Journal:  PLoS One       Date:  2019-03-22       Impact factor: 3.240

Review 10.  Beverage consumption and risk of ulcerative colitis: Systematic review and meta-analysis of epidemiological studies.

Authors:  Jia-Yan Nie; Qiu Zhao
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.